Hemodynamic-GUIDEd Management of Heart Failure
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2358 participants.
Also called NCT03387813
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 2,358 participants
- Sponsor
- Registry
-
NCT03387813
-
- Other papers using this trial's data
- Hemodynamic-Guided Heart Failure Management in Patients With Either Prior HF Hospitalization or Elevated Natriuretic Peptides
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Canada
- Registry status
- Completed
Technical summary
Registry record NCT03387813. Randomized; single masking; primary purpose treatment. Start 2018-03-15 (actual); primary completion 2023-05-17 (actual). Results posted on 2025-08-07.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Hemodynamic-GUIDEd Management of Heart Failure
- Acronym
- GUIDE-HF
- Condition
- Heart Failure
- Condition
- Heart Failure, Systolic
- Condition
- Heart Failure, Diastolic
- Condition
- Heart Failure NYHA Class II
- Condition
- Heart Failure NYHA Class III
- Condition
- Heart Failure NYHA Class IV
- Condition
- Heart Failure,Congestive
- Condition
- Heart Failure With Normal Ejection Fraction
- Condition
- Heart Failure; With Decompensation
- Intervention (Device)
- CardioMEMS™ HF System
- Lead sponsor
- Abbott Medical Devices
Record details
- Record id
cardio:ct-nct03387813- Content hash
6a6db8658797ab571cf62cab0fc2240050b2c281870d59ad3fbd913b4250d3f2